<p>当接近一半的法国公司市盈率（或称&#34;P/E&#34;）超过 17 倍时，您可能会考虑 <strong>Pernod Ricard SA</strong>（EPA:RI）作为一个具有吸引力的投资，因为它的市盈率为 11.4 倍。不过，仅仅将市盈率表面化是不明智的，因为可能有解释说明其受限的原因。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
<p>Pernod Ricard 最近的表现确实不错，因为其盈利增长是积极的，而大多数其他公司则在盈利上出现了倒退。一个可能性是，市盈率低是因为投资者认为公司的盈利很快会像其他公司一样下滑。如果不是这样，那么现有股东有理由对股价未来的走势感到相当乐观。</p>
<p>查看我们对 Pernod Ricard 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1640" height="650" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220"/></p>
<p>ENXTPA:RI 市盈率与行业比较 2026 年 1 月 6 日</p>
<p>想知道分析师如何看待 Pernod Ricard 的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
<h2>Pernod Ricard 有增长潜力吗？</h2>
<p>Pernod Ricard 的市盈率对于一家仅预期有限增长的公司来说是典型的，重要的是，其表现将低于市场。</p>
<p>如果我们回顾过去一年的盈利增长，公司实现了 11% 的可观增长。然而，这还不够，因为最近三年期间每股收益整体下降了 16%。因此，不幸的是，我们必须承认公司在这段时间内并没有很好地实现盈利增长。</p>
<p>展望未来，分析师预计接下来的三年每年将产生 0.03% 的增长。市场预计每年将实现 14% 的增长，因此公司面临较弱的盈利结果。</p>
<p>根据这些信息，我们可以看到为什么 Pernod Ricard 的市盈率低于市场。似乎大多数投资者预计未来增长有限，因此只愿意以较低的价格购买该股票。</p>
<h2>我们可以从 Pernod Ricard 的市盈率中学到什么？</h2>
<p>仅仅使用市盈率来判断是否应该出售您的股票并不明智，但它可以作为公司未来前景的实用指南。</p>
<p>我们已经确定 Pernod Ricard 维持其低市盈率是因为其预测增长低于更广泛的市场，正如预期的那样。在这个阶段，投资者认为盈利改善的潜力不足以证明更高的市盈率。在这种情况下，很难看到股价在不久的将来强劲上涨。</p>
<p>始终需要考虑投资风险的潜在威胁。<strong>我们已经发现 Pernod Ricard 的 2 个警告信号</strong>（至少有 1 个不应被忽视），理解这些信号应该是您投资过程的一部分。</p>
<p>您可能能够找到比 Pernod Ricard 更好的投资。如果您想要一些可能的候选者，请查看这份 <strong>免费</strong> 的低市盈率且已证明能够增长盈利的有趣公司名单。</p>

PRNDY

<p>Pernod Ricard SA (EPA:RI) 的市盈率为 11.4 倍，较低，这可能表明投资者对其增长预期有限。尽管最近盈利增长了 11%，但该公司在过去三年中每股收益下降了 16%。分析师预测未来三年仅有 0.03% 的年增长率，而市场预期为 14%。这表明投资者对未来盈利持谨慎态度，从而导致了低市盈率。此外，关于公司表现的警示信号也值得投资者在做出决策前考虑</p>

<p>When close to half the companies in France have price-to-earnings ratios (or &#34;P/E's&#34;) above 17x, you may consider <strong>Pernod Ricard SA</strong> (EPA:RI) as an attractive investment with its 11.4x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.</p>
<div class="lb-trans"><p>当接近一半的法国公司市盈率（或称&#34;P/E&#34;）超过 17 倍时，您可能会考虑 <strong>Pernod Ricard SA</strong>（EPA:RI）作为一个具有吸引力的投资，因为它的市盈率为 11.4 倍。不过，仅仅将市盈率表面化是不明智的，因为可能有解释说明其受限的原因。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
</div><p>Pernod Ricard certainly has been doing a good job lately as its earnings growth has been positive while most other companies have been seeing their earnings go backwards. One possibility is that the P/E is low because investors think the company's earnings are going to fall away like everyone else's soon. If not, then existing shareholders have reason to be quite optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>Pernod Ricard 最近的表现确实不错，因为其盈利增长是积极的，而大多数其他公司则在盈利上出现了倒退。一个可能性是，市盈率低是因为投资者认为公司的盈利很快会像其他公司一样下滑。如果不是这样，那么现有股东有理由对股价未来的走势感到相当乐观。</p>
</div><p>Check out our latest analysis for Pernod Ricard</p>
<div class="lb-trans"><p>查看我们对 Pernod Ricard 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220" alt="" original-src="https://images.simplywall.st/asset/chart/874314-pe-multiple-vs-industry-1-dark-2/1767672708220"/></p>
<p>ENXTPA:RI Price to Earnings Ratio vs Industry January 6th 2026</p>
<div class="lb-trans"><p>ENXTPA:RI 市盈率与行业比较 2026 年 1 月 6 日</p>
</div><p>Keen to find out how analysts think Pernod Ricard's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析师如何看待 Pernod Ricard 的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
</div><h2>Is There Any Growth For Pernod Ricard?</h2>
<div class="lb-trans"><h2>Pernod Ricard 有增长潜力吗？</h2>
</div><p>Pernod Ricard's P/E ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the market.</p>
<div class="lb-trans"><p>Pernod Ricard 的市盈率对于一家仅预期有限增长的公司来说是典型的，重要的是，其表现将低于市场。</p>
</div><p>If we review the last year of earnings growth, the company posted a worthy increase of 11%. However, this wasn't enough as the latest three year period has seen an unpleasant 16% overall drop in EPS. So unfortunately, we have to acknowledge that the company has not done a great job of growing earnings over that time.</p>
<div class="lb-trans"><p>如果我们回顾过去一年的盈利增长，公司实现了 11% 的可观增长。然而，这还不够，因为最近三年期间每股收益整体下降了 16%。因此，不幸的是，我们必须承认公司在这段时间内并没有很好地实现盈利增长。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 0.03% per annum as estimated by the analysts watching the company. With the market predicted to deliver 14% growth each year, the company is positioned for a weaker earnings result.</p>
<div class="lb-trans"><p>展望未来，分析师预计接下来的三年每年将产生 0.03% 的增长。市场预计每年将实现 14% 的增长，因此公司面临较弱的盈利结果。</p>
</div><p>With this information, we can see why Pernod Ricard is trading at a P/E lower than the market. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.</p>
<div class="lb-trans"><p>根据这些信息，我们可以看到为什么 Pernod Ricard 的市盈率低于市场。似乎大多数投资者预计未来增长有限，因此只愿意以较低的价格购买该股票。</p>
</div><h2>What We Can Learn From Pernod Ricard's P/E?</h2>
<div class="lb-trans"><h2>我们可以从 Pernod Ricard 的市盈率中学到什么？</h2>
</div><p>Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>仅仅使用市盈率来判断是否应该出售您的股票并不明智，但它可以作为公司未来前景的实用指南。</p>
</div><p>We've established that Pernod Ricard maintains its low P/E on the weakness of its forecast growth being lower than the wider market, as expected. At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio. It's hard to see the share price rising strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>我们已经确定 Pernod Ricard 维持其低市盈率是因为其预测增长低于更广泛的市场，正如预期的那样。在这个阶段，投资者认为盈利改善的潜力不足以证明更高的市盈率。在这种情况下，很难看到股价在不久的将来强劲上涨。</p>
</div><p>It's always necessary to consider the ever-present spectre of investment risk. <strong>We've identified 2 warning signs with Pernod Ricard</strong> (at least 1 which shouldn't be ignored), and understanding them should be part of your investment process.</p>
<div class="lb-trans"><p>始终需要考虑投资风险的潜在威胁。<strong>我们已经发现 Pernod Ricard 的 2 个警告信号</strong>（至少有 1 个不应被忽视），理解这些信号应该是您投资过程的一部分。</p>
</div><p>You might be able to find a better investment than Pernod Ricard. If you want a selection of possible candidates, check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>您可能能够找到比 Pernod Ricard 更好的投资。如果您想要一些可能的候选者，请查看这份 <strong>免费</strong> 的低市盈率且已证明能够增长盈利的有趣公司名单。</p>
</div>

投资者看不到 Pernod Ricard SA (EPA:RI) 隧道尽头的曙光